Under Construction

Check back soon for more IQ publications.

Recovery Animals in Toxicology Studies: An Innovation and Quality Consortium Perspective on Best Practices with Case Study Examples

International Journal of Toxicology, 2024

Salian-Mehta et al.
3Rs TPS LG

https://journals.sagepub.com/doi/abs/10.1177/10915818241243350 

Science- and Risk-Based Stability Strategies to Support Product Lifecycle Changes

The AAPS Journal, 2024

McCaig et al.
ALG

The AAPS Journal, 26(2), 34. https://doi.org/10.1208/s12248-024-00903-z

Industry’s perspective on challenges assessing the in vivo impact of removing titanium dioxide (TiO2) from drug product

Journal of Pharmaceutical Sciences, 2024

Abend et al.
ALG, DPLG

Journal of Pharmaceutical Sciences, 113(11), 3119-3122.
https://www.sciencedirect.com/science/article/pii/S0022354924003034

Evaluating Clinical Safety and Analytical Impact of Subvisible Silicone Oil Particles in Biopharmaceutical Products

Journal of Pharmaceutical Sciences, 2024

Saggu et al.
BIO LG

Journal of Pharmaceutical Sciences. 2024 Jan 12:S0022-3549(24)00007-8 
https://doi.org/10.1016/j.xphs.2024.01.002

Patient-centric Comparability Assessment of Biopharmaceuticals

Journal of Pharmaceutical Sciences, 2024

Blümel et al.

BIO LG


Journal of Pharmaceutical Sciences 113
(6), 1415-1425 
https://doi.org/10.1016/j.xphs.2024.02.010

Recommended Dose Volumes for Common Laboratory Animals

IQ Consortium, 2016

Contract Research Organization Working Group
IQ 3Rs Leadership Group

To read the article, click here.

IQ Statistics Meeting Prep Sheet

IQ Consortium, 2025

Reproducibility Working Group
IQ 3Rs Leadership Group

The purpose of this worksheet is to help scientists gather and think about certain aspects of their upcoming study, so that their first meeting with a statistician is as productive as possible. This worksheet is a general framework to be used prior to protocol development and designing an in vivo study.

To view prep sheet, click here.